The clinicopathological implications of endothelial tubuloreticular inclusions found in glomeruli having histopathology of idiopathic membranous nephropathy

Nephrology Dialysis Transplantation

Volumn 24, Issue 11, 2009, Pages 3419-3425

  Yang, An Hang ^a,b   Lin, Bing Shi ^c   Kuo, Ko Lin ^d   Chang, Chung Chen ^e   Ng, Yee Yung ^a   Yang, Wu Chang ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^d BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^e CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

Author keywords

Interferon; Membranous nephropathy; Tubuloreticular inclusion

Indexed keywords

COMPLEMENT COMPONENT C1Q;

ARTICLE; AUTOIMMUNE DISEASE; CELL INCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENDOTHELIUM CELL; FEMALE; GLOMERULUS; HELICOBACTER INFECTION; HEPATITIS; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IDIOPATHIC DISEASE; KIDNEY BIOPSY; LYMPHOMA; MALE; MEMBRANOUS GLOMERULONEPHRITIS; PRIORITY JOURNAL; PROTEINURIA; REMISSION; TREATMENT OUTCOME; TUBULORETICULAR INCLUSION; ADULT; AGED; ENDOPLASMIC RETICULUM; HELICOBACTER PYLORI; MIDDLE AGED; PATHOLOGY; ULTRASTRUCTURE;

ADULT; AGED; ENDOPLASMIC RETICULUM; ENDOTHELIAL CELLS; GLOMERULONEPHRITIS, MEMBRANOUS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KIDNEY GLOMERULUS; MIDDLE AGED;

EID: 70749092403     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfp288     Document Type: Article

References (32)

1. Luu JY, Bockus D, Remington F et al. Tubuloreticular structures and cylindrical confronting cisternae: a review. Hum Pathol 1989; 20: 617-627
2. Schaff Z, Heine U, Dalton AJ. Ultramorphological and ultracytochem-ical studies on tubuloreticular structures in lymphoid cells. Cancer Res 1972; 32: 2696-2706
3. Hammar SP, Luu JY, Bockus DE et al. Induction of tubuloreticular structures in cultured human endothelial cells by recombinant interferon alfa and beta. Ultrastruct Pathol 1992; 16:211-218
4. Grimley PM, Rutherford MN, Kang YH et al. Formation of tubuloreticular inclusions in human lymphoma cells compared to the induction of 2'-5'-oligoadenylate synthetase by leucocyte interferon in dose-effect and kinetic studies. Cancer Res 1984; 44: 3480-3488
5. Klippel JH, Carette S, Preble OT et al. Serum alpha interferon and lymphocyte inclusions in systemic lupus erythematosus. Ann Rheum Dis 1985; 44: 104-108
6. Grimley PM, Davis GL, Kang YH et al. Tubuloreticular inclusions in peripheral blood mononuclear cells related to systemic therapy with alpha-interferon. Lab Invest 1985; 52: 638-649
7. Venkataseshan VS, Marquet E, Grishman E. Significance of cytoplasmic inclusions in lupus nephritis. Ultrastruct Pathol 1991; 15: 1-14
8. Chander P, Soni A, Suri A et al. Renal ultrastructural markers in AIDS-associated nephropathy. Am J Pathol 1987; 126: 513-526
9. Gianviti A, Barsotti P, Barbera V et al. Delayed onset of systemic lupus erythematosus in patients with 'full-house' nephropathy. Pediatr Nephrol 1999; 13: 683-687
10. Petri M. Review of classification criteria for systemic lupus erythematosus. Rheum Dis Clin North Am 2005; 31: 245-254
11. Cattran D. Management of membranous nephropathy: when and what for treatment. J Am Soc Nephrol 2005; 16: 1188-1194
12. Philibert D, Cattran D. Remission of proteinuria in primary glomerulonephritis: we know the goal but do we know the price? Nat Clin PractNephrol 2008; 4: 550-559
13. Borden EC, Sen GC, Uze G et al. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov 2007; 6: 975-990
14. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 2006; 124: 783-801
15. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus an other autoimmune diseases. Immunity 2006; 25: 383-392
16. Alpers CE, Kowalewska J. Emerging paradigms in the renal pathology of viral diseases. Clin J Am Soc Nephrol 2007; 2: S6-S12
17. Wornle M, Schmid H, Banas B et al. Novel role of toll-like receptor 3 in hepatitis C-associated glomerulonephritis. Am J Pathol 2006; 168: 370-385
18. Ohtani H, Wakui H, Komatsuda A, et al. Distribution of glomerular IgG subclass deposits in malignancy-associated membranous nephropathy. Nephrol Dial Transplant 2004; 19: 574-579
19. Kuroki A, Shibata T, Honda H et al. Glomerular and serum IgG subclasses in diffuse proliferative lupus nephritis, membranous lupus nephritis, and idiopathic membranous nephropathy. Intern Med 2002; 41: 936-942
20. Muczynski KA, Ekle DM, Coder DM et al. Normal human kidney HLA-DR-expressing renal microvascular endothelial cells: characterization, isolation, and regulation of MHC class II expression. J Am Soc Nephrol 2003; 14: 1336-1348
21. Yang WS, Han NJ, Kim CS et al. STAT1-independent down-regulation of interferon-gamma-induced class II transactivator and HLA-DR expression by transforming growth factor beta-1 in human glomerular endothelial cells. Nephron Exp Nephrol 2005; 100: e124-e131
22. Suzuki T, Matsushima M, Masui A et al. Effect of Helicobacter pylori eradication in patients with chronic idiopathic thrombocytopenic purpura: a randomized controlled trial. Am J Gastroenterol 2005; 100: 1265-1270
23. Gasbarrini A, Franceschi F, Armuzzi A et al. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999; 45: I9-I12
24. Gasbarrini A, Franceschi F. Does H. pylori infection play a role in idiopathic thrombocytopenic purpura and in other autoimmune diseases? Am J Gastroenterol 2005; 100: 1271-1273
25. Kusters JG, van Vliet AH, Kuipers EJ. Pathogenesis of Helicobacter pylori infection. Clin Microbiol Rev 2006; 19: 449-490
26. Nagashima R, Maeda K, Yuda F et al. Helicobacter pylori antigen in the glomeruli of patients with membranous nephropathy. Virchows Arch 1997; 431: 235-239
27. Moriyama T, Kaneko T, Fujii M, et al. High prevalence ofHelicobacter pylori infection in Japanese patients with membranous nephropathy. Aliment Pharmacol Ther Suppl 2006; 4: 189-193
28. Sugimoto T, Furukawa T, Maeda T et al. Marked reduction of pro-teinuria after eradication of gastric Helicobacter pylori infection in a patient with membranous nephropathy: coincidental or associated? Intern Med 2007; 46: 1483-1484
29. Adu D, Williams DG, Taube D et al. Late onset systemic lupus ery-thematosus and lupus-like disease in patients with apparent idiopathic glomerulonephritis. Q J Med 1983; 52: 471-487
30. Fisher C, Gibb WR, Cohen SL et al. Lupus-like nephritis heralding the definitive manifestation of systemic lupus erythematosus. Br J Rheumatol 1985; 24: 256-262
31. Jennette JC, Iskandar SS, Dalldorf FG. Pathologic differentiation between lupus and nonlupus membranous glomerulopathy. Kidney Int 1983; 24: 377-385
32. Mosca M, Tani C, Neri C et al. Undifferentiated connective tissue diseases (UCTD). Autoimmun Rev 2006; 6: 1-4